Polymorphism in the matrix metalloproteinase-1 promoter gene and severity of rheumatoid arthritis
Massarotti, M.; Marchesoni, A.; Biondi, M.Louisa.; Marasini, B.
Journal of Rheumatology 29(10): 2241; Author Reply 2242
2002
ISSN/ISBN: 0315-162X PMID: 12375344 Document Number: 546212
Document emailed within 1 workday
Related Documents
Sugiyama, E. 2007: Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis Clinical Calcium 17(4): 528-534Yamanaka, H. 2002: Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2325-2330
Ma, J.; Wang, X.; Mo, Y.; Chen, L.; Zheng, D.; Wei, X.; Dai, L. 2015: Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis Zhonghua Yi Xue Za Zhi 95(47): 3823-3828
Ichikawa, Y.; Yamada, C.; Horiki, T.; Hoshina, Y.; Uchiyama, M. 1998: Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 533-540
Gotoh, H.; Yamada, H.; Yoshihara, Y.; Kikuchi, T.; Obata, K.; Shinmei, M. 1997: Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis Ryumachi 37(1): 3-8
Cheung, N.T.; Dawes, P.T.; Poulton, K.V.; Ollier, W.E.; Taylor, D.J.; Mattey, D.L. 2000: High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis Journal of Rheumatology 27(4): 882-887
Wu, N-qiong.; Song, L.; Hua, Y-hong.; Lu, X-feng.; Ye, J.; Li, J-xin.; Gu, D-feng.; Yang, Y-jin. 2008: Association between single nucleotide polymorphisms of matrix metalloproteinase-3 gene and the severity of coronary atherosclerosis in patients with coronary artery disease Zhonghua Xin Xue Guan Bing Za Zhi 36(6): 501-505
Gauri, L.; Kapur, S.; Pal, A.; Singh, U.; Fatima, Q.; Khan, A.; Liyakat, A.; Liyakat, N.; Kularia, R. 2019: Role of µ-Opioid Receptor Polymorphism in Patients of Rheumatoid Arthritis and their Correlation with Severity of Disease Journal of the Association of Physicians of India 67(4): 22-25
Yoshikawa, T.; Suzuki, K.; Kobayashi, O.; Sairenji, M.; Motohashi, H.; Yanoma, S.; Noguchi, Y.; Tsuburaya, A. 1998: Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1461-1464
Grover, S.; Tandon, S.; Misra, R.; Aggarwal, A. 2006: Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India Indian Journal of Medical Research 123(6): 815-820
Mafune, K. 2001: Matrix metalloproteinase (MMP), matrix serine proteinase (MSP), tissue inhibitor of metalloproteinase (TIMP) Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 176-183
Fabris, M.; Di Poi, E.; D'Elia, A.; Damante, G.; Sinigaglia, L.; Ferraccioli, G. 2002: Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis Journal of Rheumatology 29(1): 29-33
Yoshihara, Y.; Yamada, H. 2007: Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis Clinical Calcium 17(4): 500-508
Shimizu, M.; Yasuda, T.; Nakagawa, T.; Yamashita, E.; Julovi, S.M.; Hiramitsu, T.; Nakamura, T. 2003: Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines Journal of Rheumatology 30(6): 1164-1172
Vairaktaris, E.; Serefoglou, Z.; Yapijakis, C.; Vylliotis, A.; Nkenke, E.; Derka, S.; Vassiliou, S.; Avgoustidis, D.; Neukam, F.W.; Patsouris, E. 2007: High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer Anticancer Research 27(4b): 2493-2498
Zernicke, R.F.; Wohl, G.R.; Greenwald, R.A.; Moak, S.A.; Leng, W.; Golub, L.M. 1997: Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis Journal of Rheumatology 24(7): 1324-1331
Goodson, N.J.; Farragher, T.M.; Symmons, D.P.M. 2008: Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis Journal of Rheumatology 35(6): 945-949
Okada, Y.; Takeuchi, N.; Gonoji, Y.; Nakanishi, I.; Nagase, H.; Hayakawa, T. 1992: Simultaneous production of collagenase, matrix metalloproteinase 3 (stromelysin) and tissue inhibitor of metalloproteinases by rheumatoid synovial lining cells Matrix . Suppl 1: 398-399
Vairaktaris, E.; Yapijakis, C.; Nkenke, E.; Serefoglou, Z.C.; Chatzitheofylaktou, A.; Vassiliou, S.; Derka, S.; Vylliotis, A.; Perrea, D.; Neukam, F.W.; Patsouris, E. 2007: A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer Anticancer Research 27(6b): 4027-4030
Liu, P.-Y.; Chen, J.-H.; Li, Y.-H.; Wu, H.-L.; Shi, G.-Y. 2003: Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction Thrombosis and Haemostasis 90(1): 132-139